📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression. (2015)

First Author: Böttcher R

Attributed to: cAMP phosphodiesterase-4: signalling complexes, regulation and potential therapeutic targets. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2015.335

PubMed Identifier: 26575822

Publication URI: http://europepmc.org/abstract/MED/26575822

Type: Journal Article/Review

Volume: 113

Parent Publication: British journal of cancer

Issue: 10

ISSN: 0007-0920